Walleye Capital LLC Biogen Inc. Call Options Transaction History

Walleye Capital LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $8.97 Million - $11.1 Million	-47,100 Reduced 71.58%	18,700 $4.34 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $10.8 Million - $13.6 Million	50,900 Added 341.61%	65,800 $14.2 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $1.29 Million - $1.55 Million	5,800 Added 63.74%	14,900 $3.86 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.29 Million - $1.46 Million	5,100 Added 127.5%	9,100 $2.34 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $82,575 - $95,418	300 Added 8.11%	4,000 $1.14 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $359,184 - $409,275	1,400 Added 60.87%	3,700 $1.03 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $580,612 - $705,456	2,300 New	2,300 $636,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $232,794 - $308,295	-900 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $2.2 Million - $2.8 Million	-8,200 Reduced 90.11%	900 $285,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $4.49 Million - $6.2 Million	-20,400 Reduced 69.15%	9,100 $2.7 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $2.96 Million - $3.32 Million	13,600 Added 85.53%	29,500 $6.87 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $3.27 Million - $3.6 Million	14,900 Added 1490.0%	15,900 $3.72 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $216,710 - $338,960	1,000 New	1,000 $236,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.